StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

TFA Therapeutics's free cash flow for the twelve months ending Dec 31, 2023 was $40.24K. For fiscal 2024 it was -$37.23K, down 192.5% from the year before.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$37.23K-192.5%
FY2023Dec 31, 2023$40.24K–
FY2022Dec 31, 2022-$321.85K–
FY2021Dec 31, 2021-$465.36K–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023-$10.66K–

More TFA Therapeutics figures

See a number that looks wrong?